Fielder Capital Group’s Thermo Fisher Scientific TMO Stock Holding History

Fielder Capital Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$302K	Sell	614 -89	-13%	-$48.3K	0.07%	190
2025 Q4	$407K	Buy	703 +44	+7%	+$24.9K	0.09%	140
2025 Q3	$320K	Buy	+659	New	+$307K	0.07%	162
2025 Q2	–	Sell	-482	Closed	-$240K	–	258
2025 Q1	$240K	Buy	482 +27	+6%	+$14.6K	0.07%	179
2024 Q4	$237K	Sell	455 -5	-1%	-$2.75K	0.07%	180
2024 Q3	$285K	Sell	460 -18	-4%	-$10.7K	0.09%	141
2024 Q2	$264K	Buy	478 +6	+1%	+$3.44K	0.1%	140
2024 Q1	$274K	Sell	472 -9	-2%	-$5.05K	0.12%	119
2023 Q4	$255K	Buy	+481	New	+$233K	0.15%	111

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fielder Capital Group's TMO Position: Q1 2026 in Review

Fielder Capital Group reduced its Thermo Fisher Scientific (TMO) stake by 13% in Q1 2026, selling an estimated $48.3K and leaving 614 shares worth $302K. The position accounts for 0.07% of the portfolio, ranked #190.

Fielder Capital Group first reported a position in TMO in Q4 2023 and has held it in 9 quarters since. The position peaked at $407K in Q4 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Fielder Capital Group held 614 shares of Thermo Fisher Scientific worth $302K as of Q1 2026.
Fielder Capital Group sold 89 Thermo Fisher Scientific shares in Q1 2026, an estimated $48.3K.
Thermo Fisher Scientific made up 0.07% of Fielder Capital Group's portfolio in Q1 2026, its #190 holding.
Fielder Capital Group first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 9 quarters since.
Fielder Capital Group's Thermo Fisher Scientific position peaked at $407K in Q4 2025.
2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Fielder Capital Group's 13F filing for Q1 2026, filed 12 May 2026.